1 option
Medical device design and regulation / Carl T. DeMarco.
- Format:
- Book
- Author/Creator:
- DeMarco, Carl T., author.
- Language:
- English
- Subjects (All):
- Medical instruments and apparatus--United States.
- Medical instruments and apparatus.
- Medical instruments and apparatus--United States--Design and construction.
- Medical instruments and apparatus--Safety regulations--United States.
- Medical instruments and apparatus industry--United States.
- Medical instruments and apparatus industry.
- Physical Description:
- 1 online resource (368 p.)
- Edition:
- 1st ed.
- Place of Publication:
- Milwaukee, Wisconsin : ASQ Quality Press, 2011.
- Language Note:
- English
- Summary:
- The intent of this book (MDDR, for short) is to present an introduction to, and overview of, the world of medical device regulation by the United States Food and Drug Administration (FDA), and the relationship of this regulatory scheme to the design and development of medical devices. In providing this information, the book covers the broad range of requirements, which are presented within eight major topics: background and regulatory environment, device design control, nonclinical testing, clinical testing, marketing applications, post-market requirements, quality systems/GMPs, and compliance/enforcement. This book provides students and professionals in the medical device industry with a road map to the regulation of medical devices. It provides a broad understanding of the breadth and depth of medical device regulation by collecting in one textbook coverage of the regulatory scheme for medical devices in terms that are suitable for engineers, scientists, and healthcare providers. The vast amount of information available on the subject is distilled into a concise and coherent presentation.There also are problems and projects at the end of each chapter. In addition to the usual questions requiring specific answers, the projects include the drafting of a device control plan, the development of a nonclinical test procedure, the resolution of a recall, the response to a Warning Letter, and the creation of a CAPA for a device deficiency. A solutions manual for these exercises is available to teachers who adopt the textbook for classroom use or for employee training. Medical Device Design and Regulation (MDDR) also makes available over 100 complimentary live hyperlinks to web pages with additional relevant information, and offers users the opportunity to join and participate in the "MDDR Users Group" on LinkedIn.
- Contents:
- Intro
- Title Page
- CIP data
- Dedication
- Table of Contents
- List of Figures and Tables
- List of Abbreviations
- Introduction
- Acknowledgments
- Chapter 1: Background and Regulatory Environment
- Part 1. Medical Device Design and Development
- Section 1. Major Steps in the Design and Development of a Medical Device
- Section 2. Teamwork in Industry and FDA
- Section 3. Medical Device Quality, Safety, and Effectiveness
- Part 2. The Medical Device Industry
- Section 1. Industry Demographics
- Section 2. Medical Device Innovations
- Section 3. The Regulated Industry
- Part 3. United States Food and Drug Administration
- Section 1. Organizational Structure
- Section 2. FDA Decision Making
- Section 3. CD RH Strategic Priorities and Transparency
- Section 4. Division of Small Manufacturers, International and Consumer Assistance
- Section 5. FDA Foreign Offices
- Part 4. The Legal Basis for Device Regulation
- Section 1. Interstate Commerce
- Section 2. The Federal Food, Drug, and Cosmetic Act (FDCA ) and Its Evolution
- Section 3. The Medical Device Amendments of 1976
- Part 5. Quasi-Legal Requirements
- Section 1. Voluntary/Consensus Standards
- Section 2. FDA -Recognized Standards
- Section 3. Mandatory Standards
- Section 4. Guidance Documents
- Part 6. FDA Administrative Actions
- Section 1. FDA Regulations
- Section 2. Mandatory Standards
- Section 3. Administrative Hearings
- Part 7. Judicial Review
- Section 1. Agency Enforcement Actions
- Section 2. Challenging Agency Actions
- Part 8. State Regulation of Medical Devices
- Section 1. Model Uniform State Food, Drug, and Cosmetic Act
- Section 2. Preemption of State Laws and Regulations
- Part 9. International Aspects of Device Regulation
- Section 1. European Union Medical Device Regulation
- Section 2. Global Harmonization Task Force.
- Section 3. Other Requirements with International Implications
- Part 10. Confidentiality and Nonpublic Information
- Section 1. Nonpublic Information
- Section 2. Trade Secrets
- Section 3. Confidential Commercial Information
- Section 4. Financially Sensitive Information
- Section 5. Specific Patient Information
- Section 6. Specific Employee Information
- Section 7. Protecting Nonpublic Information
- Part 11. Monitoring and Auditing
- Section 1. Monitoring
- Section 2. Auditing
- Part 12. Patents
- Part 13. Medical Devices, Drugs, and Biologics
- Section 1. Medical Devices
- Section 2. Drug Products
- Section 3. Biological Products
- Section 4. Classification of Medical Devices
- Section 5. Classes of Medical Devices
- Section 6. Class I and Class II Device Exemptions
- Section 7. Restricted and Prescription Devices
- Section 8. Combination Products
- Section 9. Custom Devices
- Part 14. Exercises
- Chapter 2: Medical Device Design
- Part 1. Design Control Background
- Section 1. Overview of Design Control
- Section 2. Applicability of FDA's Design Regulation
- Section 3. International Design Control Standards
- Part 2. Design Planning and Record Keeping
- Section 1. Design Planning
- Section 2. Design History File
- Part 3. Design Inputs and Outputs
- Section 1. Design Inputs
- Section 2. Human Factors Engineering
- Section 3. Design Outputs
- Part 4. Design Verification and Design Validation
- Section 1. Verification
- Section 2. Validation
- Part 5. Design Review and Documentation
- Part 6. Design Transfer and Design Changes
- Section 1. Design Transfer
- Section 2. Design Changes
- Section 3. Documentation of Design Change
- Part 7. Design Failures
- Part 8. Exercises
- Chapter 3: Nonclinical Testing and GLPs
- Part 1. Nonclinical Testing
- Section 1. General Principles.
- Section 2. SO Ps and Protocols
- Section 3. Device Description
- Section 4. Performance Testing
- Section 5. Animal Experimentation and Evaluation
- Section 6. Biocompatibility
- Section 7. Sterility and Shelf Life
- Part 2. Good LaboratoryPractice
- Section 1. Scope and Applicability
- Section 2. The GLP Regulatory Scheme
- Section 3. Organization and Personnel
- Section 4. Facilities
- Section 5. Equipment
- Section 6. Testing Facilities Operations
- Section 7. Test and Control Articles
- Section 8. Protocols
- Section 9. Records and Reports
- Section 10. Disqualification of Testing Facilities
- Part 3. Exercises
- Chapter 4: Clinical Trials
- Good Clinical Practices
- Biostatistics
- Part 1. Background Information
- Section 1. Regulatory Scheme
- Section 2. International Guidelines for Medical Device Research
- Section 3. Major Clinical Trial Participants and Definitions
- Section 4. Ethics in Clinical Trials
- Section 5. Bias and Financial Conflicts of Interest
- Section 6. Monitoring and Auditing a Clinical Trial
- Section 7. Controls for Clinical Trials
- Part 2. Clinical Trial Design
- Section 1. The Investigational Plan
- Section 2. The Clinical Trial Protocol
- Section 3. Blinding
- Section 4. Study Controls
- Section 5. Number of Patients and Study Sites
- Section 6. Proving Safety and Effectiveness and Substantial Equivalence
- Part 3. Informed Consent
- Section 1. General Applicability
- Section 2. IR B and FDA Review and Approval of Informed Consent Form
- Section 3. Elements of Informed Consent
- Section 4. Documentation of Informed Consent
- Section 5. Emergency Use Exception from Informed Consent
- Section 6. Special Safeguards for Children
- Section 7. In Vitro Diagnostic Device (IVD) Testing
- Part 4. Institutional Review Boards
- Section 1. IRB Structure and Membership.
- Section 2. IRB Duties and Responsibilities
- Section 3. FDA Actions for Noncompliance by the IRB
- Part 5. Investigational Device Exemptions
- Section 1. Purpose of the IDE Regulation
- Section 2. The Role of Engineers and Other Scientistsin Clinical Studies
- Section 3. Applicability
- Section 4. Exempted Studies
- Section 5. Significant Risk Studies
- Section 6. Responsibilities of Sponsors
- Section 7. Responsibilities of Investigators
- Section 8. FDA Actions on IDE Applications
- Section 9. IDE Prohibitions
- Section 10. Treatment Use of an Investigational Device
- Section 11. Confidentiality of IDE Data
- Section 12. Nonsignificant Risk (NSR ) Studies
- Part 6. Bioresearch Monitoring
- Section 1. BIMO Inspections
- Section 2. Clinical Study Deficiencies
- Section 3. BIMO Enforcement Actions
- Part 7. Importing and Exporting Medical Devices for Investigational Use
- Section 1. Importing an Investigational Device
- Section 2. Exporting an Investigational Device
- Part 8. National Clinical Trials Data Bank
- Section 1. Background and Purpose
- Section 2. Exempted Clinical Trials
- Section 3. FDA Certification
- Part 9. Exercises
- Chapter 5: Marketing Applications
- The Scope of This Chapter
- Early Planning
- Part 1. Global Marketing Application Concepts
- Section 1. Overview of the Premarket Review Process
- Section 2. Valid Scientific Evidence
- Section 3. Labeling and Unapproved Uses
- Section 4. Advisory Committee Review and Outside Expertise
- Section 5. Intermediate FDA Actions During the Review Process
- Section 6. Financial Disclosure
- Section 7. Data Integrity
- Section 8. Bioresearch Monitoring
- Section 9. CDRH Electronic Copy Initiative
- Section 10. Medical Device User Fees
- Section 11. CDRH Premarket Review Submission Cover Sheet
- Part 2. Premarket Notification (510[k]).
- Section 1. Background
- Section 2. Applicability
- Section 3. Types of 510(k)s
- Section 4. The 510(k) and Substantial Equivalence
- Section 5. FDA Action on a 510(k)
- Section 6. Marketing a 510(k) Device
- Section 7. Custom Device Exemption
- Section 8. Request under Section 513(g) of the Act
- Section 9. Upcoming 510(k) Program Changes
- Part 3. PMAs/PDPs/HDEs
- Section 1. PMA Overview
- Section 2. Original PMA Submissions
- Section 3. Format and Content of a PMA Submission
- Section 4. The Determination of Safety and Effectiveness and the Summary of Safety and Effectiveness Data
- Section 5. PMA Meetings
- Section 6. FDA Actions
- Section 7. PMA Conditions of Approval Requirements
- Section 8. Post-Approval Reports
- Section 9. Adverse Reaction and Device Defect Reporting
- Section 10. Post-Approval Studies
- Section 11. PMA Supplements
- Section 12. Product Development Protocols
- Section 13. Humanitarian Device Exemptions
- Part 4. Importing and Exporting Medical Devices for Commercial Distribution
- Section 1. Importing a Medical Device
- Section 2. Exporting a Medical Device
- Part 5. Exercises
- Chapter 6: Post-Market Requirements
- Part 1. Medical Device Reporting
- Section 1. Applicability and Reportable Events
- Section 2. Reporting Responsibilities
- Section 3. Standard Operating Procedures for MDR
- Section 4. Record-Keeping Requirements
- Section 5. Exemptions, Variances, and Alternative Reporting Requirements
- Section 6. Public Disclosure of MDR Information
- Part 2. Post-market Surveillance Studies
- Section 1. Applicability and Scope
- Section 2. The PS Submission and PS Plan
- Section 3. FDA Actions
- Part 3. Medical Device Tracking
- Section 2. Devices Subject to Tracking
- Section 3. The Tracking Process
- Section 4. Records and Reports.
- Part 4. Medical Device Recalls.
- Notes:
- Description based upon print version of record.
- Includes bibliographical references and index.
- Description based on print version record.
- ISBN:
- 9780873891875
- 0873891872
- 9780873891882
- 0873891880
- 9786000049300
- 6000049307
- OCLC:
- 893681506
The Penn Libraries is committed to describing library materials using current, accurate, and responsible language. If you discover outdated or inaccurate language, please fill out this feedback form to report it and suggest alternative language.